UgeneX

UgeneX Therapeutics, established in July 2021, is a biotechnology company focused on developing innovative drugs for the treatment of ophthalmic diseases. The novel gene therapy strategy developed by UgeneX Therapeutics involves in-situ regeneration of missing neurons by leveraging other neural cell types within the patient's retina, offering the potential to restore vision to blind patients. Additionally, this new gene therapy approach, based on the regenerative potential of neural cells, can also be applied to other parts of the nervous system, providing the possibility for treating other neurological disorders.